Product Information
ELYXYB 120 MG/4.8 ML SOLUTION is a brand product labeled by Scilex Pharmaceuticals Inc., priced at $30.5381 per ML under NDC 69557033301. Its NADAC has been published 137 times since Feb 21, 2024.
FDA first approved this application on May 5, 2020.
The High Outlier badge above means this manufacturer's average price in the celecoxib market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
120 mg/4.8mL
Manufacturer
Scilex Pharmaceuticals Inc.NDC
69557033301
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CELECOXIBApproval Type
New Drug (NDA)
FDA Application
NDA212157FDA Approved
5/5/2020
On Market Since
11/27/2023
Pharmacological Classes
Price Statistics
The NADAC for ELYXYB 120 MG/4.8 ML SOLUTION has been published 137 times since Feb 21, 2024, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $30.5381 per ML |
|---|---|
| All-time high | $30.6503 (Jun 10, 2026) |
| All-time low | $28.3971 (May 22, 2024) |
| 52-week high | $30.6503 |
| 52-week low | $29.1940 |
| Median price | $29.1555 |
| Average price | $29.4818 |
| Largest weekly change | +4.9% (Jan 14, 2026) |
| Weeks tracked | 137 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the celecoxib market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Scilex Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ELYXYB 120 MG/4.8 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ELYXYB 120 MG/4.8 ML SOLUTION, manufactured by Scilex Pharmaceuticals Inc., is $30.5381 per ML (NDC 69557033301), effective Sep 30, 2026.
How has the price of ELYXYB 120 MG/4.8 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ELYXYB 120 MG/4.8 ML SOLUTION has risen 5.7%. It has been tracked across 137 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for ELYXYB 120 MG/4.8 ML SOLUTION?
Since Feb 21, 2024, the NADAC for ELYXYB 120 MG/4.8 ML SOLUTION has ranged from a low of $28.3971 (May 22, 2024) to a high of $30.6503 (Jun 10, 2026), with a median of $29.1555 per ML.
Are there cheaper alternatives to ELYXYB 120 MG/4.8 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of ELYXYB 120 MG/4.8 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ELYXYB 120 MG/4.8 ML SOLUTION?
ELYXYB 120 MG/4.8 ML SOLUTION (NDC 69557033301) is labeled by Scilex Pharmaceuticals Inc., and CMS classifies it as a brand product.